Inflammation and prolonged QT time: Results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Medenwald, Daniel ^a   Kors, Jan A ^b   Loppnow, Harald ^a   Thiery, Joachim ^c   Kluttig, Alexander ^a   Nuding, Sebastian ^b   Tiller, Daniel ^a   Greiser, Karin H ^d   Werdan, Karl ^b   Haerting, Johannes ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR 1; AUTACOID; IL6 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AGING; ARRHYTHMOGENESIS; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; QT PROLONGATION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; VERY ELDERLY; ARRHYTHMIAS, CARDIAC; BLOOD; CROSS-SECTIONAL STUDY; GERMANY; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STATISTICAL MODEL; URBAN POPULATION;

AGED; AGED, 80 AND OVER; AGING; ARRHYTHMIAS, CARDIAC; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LINEAR MODELS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA; URBAN POPULATION;

EID: 84899766594     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095994     Document Type: Article

References (49)

1. Viskin S (1999) Long QT syndromes and torsade de pointes. The Lancet 354 (9190): 1625-1633.
2. Gowd BMP, Thompson PD (2012) Effect of Female Sex on Cardiac Arrhythmias. Cardiol Rev 20 (6): 297-303.
3. Morita H, Wu J, Zipes DP (2008) The QT syndromes: long and short. The Lancet 372 (9640): 750-763.
4. Kazumi T, Kawaguchi A, Hirano T, Yoshino G (2003) C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metab. Clin. Exp. 52 (9): 1113-1116. (Pubitemid 37203483)
5. Kim E, Joo S, Kim J, Ahn J, Kim J, et al. (2006) Association between C-reactive protein and QTc interval in middle-aged men and women. Eur J Epidemiol 21 (9): 653-659. (Pubitemid 44730337)
6. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, et al. (2000) Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure. Circulation 102 (25): 3060-3067.
7. Ueland T, Kjekshus J, Frøland SS, Omland T, Squire IB, et al. (2005) Plasma Levels of Soluble Tumor Necrosis Factor Receptor Type I During the Acute Phase Following Complicated Myocardial Infarction Predicts Survival in High-Risk Patients. J Am Coll Cardiol 46 (11): 2018-2021. (Pubitemid 41713585)
8. Kleinbongard P, Schulz R, Heusch G (2011) TNFa in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail Rev 16 (1): 49-69.
9. Greensmith DJ, Nirmalan M (2013) The effects of tumor necrosis factor-alpha on systolic and diastolic function in rat ventricular myocytes. Physiol Rep 1(4): e00093.
10. Stengl M, Bartak F, Sykora R, Chvojka J, Benes J, et al. (2010) Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock. Crit. Care Med. 38 (2): 579-587.
11. Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, et al. (2006) Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am. J. Physiol. Heart Circ.Physiol. 290 (5): H2098-107.
12. Fernández-Velasco M, Ruiz-Hurtado G, Hurtado O, Moro MA, Delgado C (2007) TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation. Am. J. Physiol. Heart Circ. Physiol. 293 (1): H238-45. (Pubitemid 47105078)
13. Duncan DJ, Yang Z, Hopkins PM, Steele DS, Harrison SM (2010) TNF-α and IL-1β increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium 47 (4): 378-386.
14. Carpena N, Roselló-Lletí E, Calabuig JR, Tarazón E, González-Juanatey JR, et al. (2012) MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study. ISRN Cardiol 2012: 501894.
15. Guo Y, Lip GY, Apostolakis S (2012) Inflammation in Atrial Fibrillation. J Am Coll Cardiol 60 (22): 2263-2270.
16. Hijazi Z, Oldgren J, Siegbahn A, Granger CB, Wallentin L (2013) Biomarkers in atrial fibrillation: a clinical review. Eur Heart J 34 (20): 1475-1480.
17. Greiser KH, Kluttig A, Schumann B, Kors JA, Swenne CA, et al. (2005) Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study. BMC Cardiovasc Disord 5: 33.
18. Greiser KH, Kluttig A, Schumann B, Swenne CA, Kors JA, et al. (2009) Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: the CARLA study 2002-2006. Eur J Epidemiol 24 (3): 123-142.
19. Rickham PP (1964) Human experimentation. Code of Ethics of the World Medical Association. Declaration of Helsinki. Br Med J 2 (5402): 177.
20. Prineas RJ CRBH (1982) The Minnesota code manual of electrocardiographic findings. Standard procedures for measurement and classification. Boston: John Wright PSB.
21. van Bemmel JH, Kors JA, van Herpen G (1990) Methodology of the modular ECG analysis system MEANS. Methods Inf Med 29 (4): 346-353. (Pubitemid 20311457)
22. Bruyne MC de, Hoes AW, Kors JA, Hofman A, van Bemmel JH, et al. (1999) Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J 20 (4): 278-284. (Pubitemid 29082148)
23. Kors JA, van Herpen G (2009) Methodology of QT-Interval Measurement in the Modular ECG Analysis System (MEANS). Ann Noninvasive Electrocardiol 14: S48.
24. Bazett H (1920) An analysis of the time-relations of electrocardiograms. Heart 7: 35-70.
25. Rautaharju PM, Surawicz B, Gettes LS (2009) AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram. J Am Coll Cardiol 53 (11): 982-991.
26. Goldenberg I, Moss AJ, Zareba W (2006) QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol 17 (3): 333-336. (Pubitemid 43344951)
27. Desquilbet L, Mariotti F (2010) Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29 (9): 1037-1057.
28. Galetta F, Franzoni F, Fallahi P, Tocchini L, Braccini L, et al. (2008) Changes in heart rate variability and QT dispersion in patients with overt hypothyroidism. Eur J Endocrinol 158 (1): 85-90. (Pubitemid 351211044)
29. Textor J, Hardt J, Knüppel S (2011) DAGitty. Epidemiology 22 (5): 745.
30. VanderWeele TJ, Robins JM (2007) Four Types of Effect Modification. Epidemiology 18 (5): 561-568.
31. Shrier I, Platt RW (2008) Reducing bias through directed acyclic graphs. BMC Med Res Methodol 8 (1): 70.
32. Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10 (1): 37-48. (Pubitemid 29014427)
33. Sedlak T, Shufelt C, Iribarren C, Merz CNB (2012) Sex Hormones and the QT Interval: A Review. J Womens Health 21 (9): 933-941.
34. Tiller D, Russ M, Greiser KH, Nuding S, Ebelt H, et al. (2013) Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study. PLoS ONE 8 (3): e59225.
35. Johnson JN, Grifoni C, Bos JM, Saber-Ayad M, Ommen SR, et al. (2011) Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy. Eur Heart J 32 (9): 1114-1120.
36. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (4): 236-241. (Pubitemid 20225044)
37. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, et al. (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93 (4): 704-711.
38. Safranow K, Dziedziejko V, Rzeuski R, Czyz-ycka E, Wojtarowicz A, et al. (2009) Plasma concentrations of TNF-α and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease. Tissue Antigens 74 (5): 386-392.
39. Park E, Cho S, Frys KA, Glickstein SB, Zhou P, et al. (2006) Inducible nitric oxide synthase contributes to gender differences in ischemic brain injury. J. Cereb. Blood Flow Metab. 26 (3): 392-401.
40. Gaborit N, Varro A, Le Bouter S, Szuts V, Escande D, et al. (2010) Gender-related differences in ion-channel and transporter subunit expression in non-diseased human hearts. J. Mol. Cell. Cardiol. 49 (4): 639-646.
41. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, et al. (2004) Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women. N Engl J Med 351 (25): 2599-2610. (Pubitemid 39628581)
42. Stice JP, Chen L, Kim S, Jung JS, Tran AL, et al. (2011) 17 -Estradiol, Aging, Inflammation, and the Stress Response in the Female Heart. Endocrinology 152 (4): 1589-1598.
43. Severi S, Ciandrini A, Grandi E, Cavalcanti S, Bini S, et al. (2006) Cardiac response to hemodialysis with different cardiovascular tolerance: Heart rate variability and QT interval analysis. Hemodialysis Int 10 (3): 287-293. (Pubitemid 43923213)
44. Boos CJ, Anderson R A, Lip GY (2005) Is atrial fibrillation an inflammatory disorder. Eur Heart J 27 (2): 136-149.
45. Boos CJ, Lip GY (2008) Inflammation and atrial fibrillation: cause or effect. Heart 94 (2): 133-134. (Pubitemid 351211714)
46. Schuessler RB, Ishii Y, Khagi Y, Diabagate K, Boineau JP, et al. (2012) The effects of inflammation on heart rate and rhythm in a canine model of cardiac surgery. Heart Rhythm 9 (3): 432-439.
47. Clendenen TV, Koenig KL, Arslan AA, Lukanova A, Berrino F, et al. (2011) Factors associated with inflammation markers, a cross-sectional analysis. Cytokine 56 (3): 769-778.
48. Loppnow H, Werdan K, Werner C (2002) The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist. Auton Autacoid Pharmacol 22 (2): 83-92. (Pubitemid 36687460)
49. Ohtsuka T, Hamada M, Hiasa G, Sasaki O, Suzuki M, et al. (2001) Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 37 (2): 412-417.